Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT06409845
Effectiveness and Tolerability of Eptinezumab
Sponsor: University of Florence
View on ClinicalTrials.gov
Summary
The purpose of this prospective and multicentric study is to evaluate the effectiveness and tolerability of eptinezumab as preventive migraine treatment in a cohort of episodic or chronic migraine patients.
Official title: Effectiveness and Tolerability of Eptinezumab: a Prospective, Multicentric, Cohort Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
130
Start Date
2024-03-26
Completion Date
2026-04-01
Last Updated
2026-06-11
Healthy Volunteers
No
Interventions
DRUG
Eptinezumab 100 or 300 mg ev
Patients administered eptinezumab 100 or 300 mg ev quarterly for migraine prevention
Locations (1)
SISC
Florence, Florence, Italy